# 2025年11月23日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 生理学指导下对不适合ECMO治疗的严重低氧血症患者的管理：多学科肺拯救团队的策略

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41272741](https://pubmed.ncbi.nlm.nih.gov/41272741)
**期刊：** Critical care (London, England)
**PMID：** 41272741
**DOI：** 10.1186/s13054-025-05709-9

### 第一部分 原文与翻译

**英文原标题：** Physiology-guided management of patients with severe hypoxemia ineligible for ECMO: a multidisciplinary lung rescue team approach.

**英文摘要原文：**
No abstract available.

**中文摘要译文：**
无可用摘要。

### 第二部分 AI 大师评价

该研究针对无法接受ECMO治疗的严重低氧血症这一棘手临床难题，提出了一种基于生理学指导的多学科肺拯救团队管理策略。该方法的核心创新在于，通过整合多学科专业知识，并依据患者的实时生理学参数来动态调整治疗方案，从而实现精准、个性化的呼吸支持。尽管缺乏摘要信息，但该标题揭示了一种极具临床应用价值的系统化管理模式，对于优化危重患者救治流程、改善预后具有重要启示意义，为缺乏高级生命支持条件的临床情境提供了宝贵的实践参考。

---

## 2. 重症监护室谵妄预防与管理干预措施的系统性荟萃综述：第二部分 - 非药物与多组分干预

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41272698](https://pubmed.ncbi.nlm.nih.gov/41272698)
**期刊：** Critical care (London, England)
**PMID：** 41272698
**DOI：** 10.1186/s13054-025-05726-8

### 第一部分 原文与翻译

**英文原标题：** A systematic meta-review of interventions to prevent and manage delirium in the Intensive Care Unit: Part 2 - Non-pharmacological and multicomponent interventions.

**英文摘要原文：**
No abstract available.

**中文摘要译文：**
无可用摘要。

### 第二部分 AI 大师评价

本研究是一篇针对ICU中谵妄预防与管理的系统性荟萃综述，其重点是评估非药物及多组分干预措施的有效性。通过整合分析已有的元分析和系统综述，该研究旨在为临床实践提供关于此类干预的最高级别证据总结。尽管缺乏摘要信息，但该研究的价值在于为制定ICU谵妄非药物防治策略提供了全面的证据基础，对于优化患者预后、减少药物使用具有重要的临床指导意义，是该主题系列综述的第二部分，显示了其研究的系统性和深度。

---

## 3. 伪激酶STK40通过COP1依赖性降解AP1家族转录因子来限制T细胞耗竭

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41272167](https://pubmed.ncbi.nlm.nih.gov/41272167)
**期刊：** Nature immunology
**PMID：** 41272167
**DOI：** 10.1038/s41590-025-02333-1

### 第一部分 原文与翻译

**英文原标题：** Pseudokinase STK40 limits T cell exhaustion through COP1-dependent degradation of AP1-family transcription factors.

**英文摘要原文：**
Serine/threonine kinase 40 (STK40) belongs to the Tribbles family of pseudokinases, which serve as substrate adaptors for the CRL4 E3 ubiquitin ligase complex. Tribbles-1 and Tribbles-2 promote the degradation of CCAAT/enhancer-binding protein (C/EBP) transcription factors in hematopoietic cells. STK40 also regulates C/EBP proteins, and although some immune system functions have recently emerged, its specific role in cytotoxic T cell responses has not been characterized. Here we show that murine STK40 restricts homeostatic and antigen-driven T cell expansion. During chronic viral infection, T cell-specific deletion of Stk40 improved viral clearance and reduced the proportion of terminally exhausted antigen-specific T cells. STK40-deficient T cells exhibited increased expression of markers of cell proliferation and AP-1 target genes. Biochemically, STK40 interacted with the AP-1 transcription factor c-Jun, and was required for its CRL4-dependent proteasomal degradation. Collectively, our results identify the COP1/STK40 axis as a post-translational cell-intrinsic mechanism regulating T cell immunity.

**中文摘要译文：**
丝氨酸/苏氨酸激酶40（STK40）属于Tribbles伪激酶家族，该家族成员可作为CRL4 E3泛素连接酶复合物的底物衔接蛋白。Tribbles-1和Tribbles-2在造血细胞中能促进CCAAT/增强子结合蛋白（C/EBP）转录因子的降解。STK40同样调节C/EBP蛋白，尽管最近发现其具有某些免疫系统功能，但其在细胞毒性T细胞应答中的特异性作用尚未被阐明。本研究显示，鼠源STK40限制了T细胞的稳态扩增和抗原驱动的扩增。在慢性病毒感染期间，T细胞特异性地敲除Stk40改善了病毒清除效果，并降低了终末耗竭性抗原特异性T细胞的比例。STK40缺陷的T细胞表现出细胞增殖标志物和AP-1靶基因的表达增加。从生物化学角度看，STK40与AP-1转录因子c-Jun相互作用，并且是其CRL4依赖性质谱酶体降解所必需的。总而言之，我们的研究结果确定了COP1/STK40轴是调控T细胞免疫的一种翻译后细胞内在机制。

### 第二部分 AI 大师评价

该研究揭示了伪激酶STK40在调控T细胞功能中的一个全新角色，尤其是在慢性病毒感染背景下对T细胞耗竭的限制作用。研究团队通过T细胞特异性基因敲除小鼠模型，明确了STK40能够抑制T细胞的增殖和抗病毒能力。其核心创新在于，首次阐明了STK40通过作为CRL4 E3泛素连接酶复合物的接头蛋白，介导COP1依赖性的AP-1家族转录因子（如c-Jun）降解，从而发挥其免疫抑制功能。这一发现不仅为理解T细胞耗竭的分子机制提供了新的视角，也提示STK40可能成为一个有潜力的免疫治疗靶点，用于增强抗肿瘤或抗感染免疫。

---

## 4. 干扰素介导的NK细胞活化增强其对T滤泡辅助细胞的细胞毒性活性，从而限制对SARS-CoV-2的抗体应答

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41272165](https://pubmed.ncbi.nlm.nih.gov/41272165)
**期刊：** Nature immunology
**PMID：** 41272165
**DOI：** 10.1038/s41590-025-02341-1

### 第一部分 原文与翻译

**英文原标题：** Interferon-mediated NK cell activation increases cytolytic activity against T follicular helper cells and limits antibody response to SARS-CoV-2.

**英文摘要原文：**
Natural killer (NK) cells are innate lymphocytes known for their ability to kill infected or malignant cells, but they have an overlooked role in regulating antibody responses. In mice, NK cells can kill T follicular helper (Tfh) cells, decreasing somatic hypermutation and antibody titers. Although human NK cell activation correlates with poor vaccine response, the mechanisms of NK cell regulation of adaptive immunity in humans are poorly understood. Here we found that, in ancestral severe acute respiratory syndrome coronavirus 2 infection, individuals with the broadest neutralization profile had fewer NK cells that expressed inhibitory and immaturity markers, whereas NK cells from narrow neutralizers were highly activated and expressed interferon-stimulated genes. ISG-mediated activation in NK cells from healthy donors increased cytotoxicity toward induced Tfh-like cells via NKG2D and NKp30. This work reveals that NK cell activation and dysregulated inflammation play a role in poor antibody response to severe acute respiratory syndrome coronavirus 2 and opens exciting avenues for designing improved vaccines and adjuvants to target emerging pathogens.

**中文摘要译文：**
自然杀伤（NK）细胞是先天性淋巴细胞，以其杀伤受感染或恶性细胞的能力而闻名，但它们在调节抗体应答中的作用却被忽视了。在小鼠中，NK细胞能够杀伤T滤泡辅助（Tfh）细胞，从而减少体细胞高频突变和抗体滴度。尽管人类NK细胞的活化与较差的疫苗应答相关，但人类NK细胞调节适应性免疫的机制尚不明确。在本研究中我们发现，在感染原始株严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的个体中，具有最广泛中和能力的个体其表达抑制性和未成熟标志物的NK细胞较少，而中和能力较窄的个体其NK细胞则高度活化并表达干扰素刺激基因（ISG）。在来自健康捐赠者的NK细胞中，ISG介导的活化通过NKG2D和NKp30增强了对诱导的Tfh样细胞的细胞毒性。这项工作揭示了NK细胞活化和失调的炎症反应在导致对SARS-CoV-2抗体应答不佳中发挥了作用，并为设计针对新兴病原体的改良疫苗和佐剂开辟了激动人心的新途径。

### 第二部分 AI 大师评价

该研究旨在揭示人类NK细胞在调控对SARS-CoV-2适应性免疫应答中的具体机制。研究通过对比分析新冠感染者体内NK细胞的表型与其中和抗体谱的关系，并结合体外实验，发现干扰素刺激基因（ISG）介导的NK细胞过度活化会增强其对T滤泡辅助细胞（Tfh）的杀伤作用。这一关键发现创新性地阐明了NK细胞活化与抗体应答质量不佳之间的负向调控通路，为优化疫苗设计与佐剂开发提供了新的靶点和思路，即通过调控NK细胞的活化状态来提升抗体应答的广度与效力。

---

## 5. 产前热暴露与早产的关键窗口期：一项基于亚特兰大非裔美国人母婴队列的代谢组学研究

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41270169](https://pubmed.ncbi.nlm.nih.gov/41270169)
**期刊：** Science advances
**PMID：** 41270169
**DOI：** 10.1126/sciadv.adw8328

### 第一部分 原文与翻译

**英文原标题：** Critical windows of prenatal heat exposure and preterm birth: Metabolomic study in the Atlanta African American Maternal-Child Cohort.

**英文摘要原文：**
Extreme heat is a risk factor for preterm birth (PTB), but the underlying biological pathways remain poorly understood. This study aimed to identify maternal metabolomic signatures associated with prenatal heat exposure and PTB. We conducted a prospective analysis of 215 participants in the Atlanta African American Maternal-Child Cohort (2014 to 2020). Serum samples collected during early and late pregnancy underwent untargeted metabolomic profiling. Daily maximum ambient temperature was estimated at geocoded residential addresses and averaged over three exposure windows: conception to early pregnancy, early to late pregnancy, and conception to late pregnancy. Metabolome-wide association studies were performed for each exposure window and PTB, followed by a meet-in-the-middle analysis. We identified 23 metabolic pathways and four overlapping metabolites, including methionine, proline, citrulline, and pipecolate, associated with both temperature exposure and PTB. These metabolites are involved in amino acid metabolism and oxidative stress regulation. Findings highlight the potential of metabolomics to detect early biological alterations linked to environmental risk and adverse birth outcomes.

**中文摘要译文：**
极端高温是早产（PTB）的一个风险因素，但其潜在的生物学通路仍知之甚少。本研究旨在识别与产前热暴露及早产相关的母体代谢组学特征。我们对亚特兰大非裔美国人母婴队列中的215名参与者（2014年至2020年）进行了一项前瞻性分析。在妊娠早期和晚期收集的血清样本接受了非靶向代谢组学分析。每日最高环境温度通过地理编码的住宅地址进行估算，并在三个暴露窗口期内取平均值：从受孕到妊娠早期、从妊娠早期到晚期，以及从受孕到妊娠晚期。我们针对每个暴露窗口期和早产进行了全代谢组关联研究，随后进行了“中间相遇”分析。我们识别出23条代谢通路和4种重叠的代谢物（包括蛋氨酸、脯氨酸、瓜氨酸和哌啶酸），它们均与温度暴露和早产相关。这些代谢物参与了氨基酸代谢和氧化应激调节。研究结果凸显了代谢组学在检测与环境风险和不良妊娠结局相关的早期生物学改变方面的潜力。

### 第二部分 AI 大师评价

本研究巧妙地运用代谢组学方法，旨在揭示产前热暴露与早产风险之间潜在的生物学机制。通过对一个特定族裔母婴队列的前瞻性分析，并结合“中间相遇”这一创新性分析策略，研究成功筛选出与热暴露和早产均相关的关键代谢物（如蛋氨酸、脯氨酸等）及通路，直指氨基酸代谢和氧化应激在其中的核心作用。该发现不仅为理解环境因素如何影响妊娠结局提供了新的分子层面的证据，也为未来开发早期预警生物标志物和干预策略开辟了新途径，具有重要的公共卫生与临床转化价值。

---

## 6. 不含B细胞表位的保守性CD8 T细胞疫苗可针对SARS-CoV-2提供强有力的保护，且鼻内加强免疫可增强此效应

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41270167](https://pubmed.ncbi.nlm.nih.gov/41270167)
**期刊：** Science advances
**PMID：** 41270167
**DOI：** 10.1126/sciadv.adx0037

### 第一部分 原文与翻译

**英文原标题：** Conserved CD8 T cell vaccines without B cell epitopes drive robust protection against SARS-CoV-2 that is enhanced by intranasal boost.

**英文摘要原文：**
The emergence of SARS-CoV-2 variants has challenged the current spike protein-focused COVID-19 vaccine strategy due to neutralizing antibody escape and waning antibody-mediated immunity. In contrast, T cell-mediated immunity targeting conserved epitopes may offer broad and long-lasting protection. However, whether T cells alone can provide sufficient protection remains unclear. Here, we identified both Omicron BA.1-specific and ancestral (Wuhan)-conserved CD8 T cell epitopes in the SARS-CoV-2 spike protein and evaluated them as carrier-protein fusion vaccines in mouse models. Subcutaneous immunizations with two CD8 epitope peptides substantially lowered lung viral load and conferred protection against low-dose viral challenge, but not against high-dose challenge. Notably, intranasal boosting-with or without adjuvant-enhanced lung resident memory T cell responses and conferred potent, durable protection against high-dose infection. These findings emphasize the importance of mucosal vaccination to boost protective T cell immunity against SARS-CoV-2 and support the potential of T cell-based vaccines targeting conserved epitopes for broad immunity against SARS-CoV-2 and other respiratory viral threats.

**中文摘要译文：**
SARS-CoV-2变异株的出现，因其中和抗体逃逸及抗体介导免疫力减弱的特性，对当前以刺突蛋白为重点的COVID-19疫苗策略构成了挑战。相比之下，靶向保守表位的T细胞介导免疫可能提供广泛而持久的保护。然而，仅靠T细胞是否能提供足够的保护仍不明确。在本研究中，我们在SARS-CoV-2刺突蛋白中鉴定了Omicron BA.1特异性以及从原始（武汉）毒株中保守下来的CD8 T细胞表位，并在小鼠模型中将其作为载体蛋白融合疫苗进行了评估。采用两种CD8表位肽进行皮下免疫，显著降低了肺部病毒载量，并能抵御低剂量病毒攻击，但对高剂量攻击无效。值得注意的是，无论是否使用佐剂，鼻内加强免疫均能增强肺部驻留记忆T细胞反应，并针对高剂量感染提供了强效、持久的保护。这些发现强调了通过黏膜疫苗接种来增强针对SARS-CoV-2的保护性T细胞免疫的重要性，并支持了靶向保守表位的T细胞疫苗在实现对SARS-CoV-2及其他呼吸道病毒威胁的广泛免疫方面的潜力。

### 第二部分 AI 大师评价

本研究旨在探索一种不依赖抗体的、靶向SARS-CoV-2保守区域的T细胞疫苗的保护效果。研究者通过在小鼠模型中进行皮下初免和鼻内加强免疫，发现这种策略能有效诱导肺部驻留记忆T细胞，并提供针对高剂量病毒攻击的强效持久保护。此项工作创新性地证实了单纯的T细胞免疫足以抵抗病毒感染，并凸显了黏膜加强免疫在呼吸道病毒防护中的关键作用，为开发广谱、抗变异的下一代新冠疫苗及其他呼吸道病毒疫苗提供了重要的实验依据。

---

## 7. 扩展观察性医疗结果合作伙伴关系（OMOP）通用数据模型以用于危重症医学：一个利用重症监护医学会危重症护理数据字典（C2D2）标准化复杂ICU数据的框架。

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41269063](https://pubmed.ncbi.nlm.nih.gov/41269063)
**期刊：** Critical care medicine
**PMID：** 41269063
**DOI：** 10.1097/CCM.0000000000006969

### 第一部分 原文与翻译

**英文原标题：** Extending the Observational Medical Outcomes Partnership (OMOP) Common Data Model for Critical Care Medicine: A Framework for Standardizing Complex ICU Data Using the Society of Critical Care Medicine's Critical Care Data Dictionary (C2D2).

**英文摘要原文：**
OBJECTIVES: To evaluate the compatibility of the Society of Critical Care Medicine's (SCCM) Critical Care Data Dictionary (C2D2) with the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) and initiate a set of steps extending OMOP to accommodate specialized critical care data elements.

DESIGN: Systematic analysis and mapping study using a three-tiered semantic matching approach to demonstrate technical feasibility and identify fundamental challenges in critical care data standardization.

SETTING: Critical care medicine informatics research environment.

SUBJECTS: The SCCM's C2D2 elements.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: We evaluated the compatibility of C2D2 clinical variables with the OMOP CDM using a three-tier classification system (full match, partial match, and no match). Our analysis of 226 C2D2 elements revealed that 49.6% of concepts had full OMOP equivalents, 46.4% required modification, and 4.0% had no suitable mapping. Key incompatibilities were identified in ventilator parameters, composite scoring systems, and advanced organ support documentation. A large language model-based semantic matching system yielded a precision of 59.5%, recall of 87.0%, and F1 score of 70.7% at an optimized similarity threshold of 0.90. These findings highlight the need to harmonize data standardization approaches within the field of critical care, including how to handle concept stacking within single variables, age-specific criteria, and specialized constructs that were curated through the SCCM Delphi process, but reveal an OMOP mapping incompatibility or missing variables.

CONCLUSIONS: Extending the OMOP CDM for critical care is technically feasible and requires targeted modifications to accommodate composite scores, temporal precision, and specialized critical care concepts as well as the resources needed to support this build. The community acutely faces crucial decisions about whether to pursue OMOP integration, adapt the C2D2 for version 2.0 compatibility, work toward OMOP vocabulary inclusion through Observational Health Data Sciences and Informatics processes, or collaborate with electronic health record vendors for native critical care standards support. These decisions require balancing technical feasibility with long-term sustainability and maintenance considerations.

**中文摘要译文：**
目的：评估重症监护医学会（SCCM）的危重症护理数据字典（C2D2）与观察性医疗结果合作伙伴关系（OMOP）通用数据模型（CDM）的兼容性，并启动一系列步骤以扩展OMOP，从而容纳专门的危重症护理数据元素。

设计：采用三层语义匹配方法的系统性分析和映射研究，以证明技术可行性并识别危重症数据标准化中的根本性挑战。

地点：危重症医学信息学研究环境。

对象：SCCM的C2D2元素。

干预：无。

测量与主要结果：我们使用三级分类系统（完全匹配、部分匹配和无匹配）评估了C2D2临床变量与OMOP CDM的兼容性。我们对226个C2D2元素的分析显示，49.6%的概念有完全的OMOP等效项，46.4%需要修改，而4.0%没有合适的映射。在呼吸机参数、复合评分系统和高级器官支持文档中发现了关键的不兼容性。一个基于大型语言模型的语义匹配系统，在优化的相似度阈值为0.90时，其精确率为59.5%，召回率为87.0%，F1评分为70.7%。这些发现凸显了在危重症领域内协调数据标准化方法的必要性，包括如何处理单个变量内的概念堆叠、年龄特异性标准以及通过SCCM德尔菲法流程筛选出的、但显示出OMOP映射不兼容或变量缺失的专门构建概念。

结论：为危重症护理扩展OMOP CDM在技术上是可行的，但这需要进行有针对性的修改以适应复合评分、时间精度和专门的危重症概念，并需要资源来支持这一构建工作。学界正迫切面临关键决策：是继续推进OMOP整合，还是调整C2D2以兼容2.0版本，或是通过观察性健康数据科学与信息学流程致力于将概念纳入OMOP词汇表，又或是与电子健康记录供应商合作以支持原生的危重症标准。这些决策需要在技术可行性与长期可持续性和维护考量之间取得平衡。

### 第二部分 AI 大师评价

本研究旨在评估重症监护医学会危重症护理数据字典（C2D2）与广泛应用的OMOP通用数据模型的兼容性，为标准化复杂的ICU数据提供了框架。研究通过系统性映射分析发现，近半数C2D2概念需要修改才能与OMOP匹配，尤其在呼吸机参数、复合评分系统等领域存在关键不兼容性。该研究的创新之处在于其系统性地量化了两大标准之间的差距，并验证了利用大语言模型进行语义匹配的可行性，为实现大规模、多中心危重症数据整合与研究奠定了关键的信息学基础，对未来数据驱动的精准重症医学发展具有重要指导意义。

---

## 8. 毁灭性脑损伤患者中错失的器官捐献机会：一项基于人群的前瞻性队列研究

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41269058](https://pubmed.ncbi.nlm.nih.gov/41269058)
**期刊：** Critical care medicine
**PMID：** 41269058
**DOI：** 10.1097/CCM.0000000000006950

### 第一部分 原文与翻译

**英文原标题：** Missed Organ Donation Opportunities in Patients With Devastating Brain Injury: A Prospective Population-Based Cohort Study.

**英文摘要原文：**
OBJECTIVES: Determine the incidence and predictors of missed organ donation opportunities.

DESIGN: Population-based, prospective cohort study.

SETTING: All adult ICU and PICU (medical, surgical, neurologic, and cardiovascular) and emergency departments (EDs) in a Canadian province with a population of 5 million.

PATIENTS: Consecutive patients that died with devastating brain injury, regardless of etiology, and were mechanically ventilated in the last 12 hours of life over a period of 42 months.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Patients were defined as eligible potential donors if they were diagnosed with death by neurologic criteria (DNC), probable DNC (neurologic examination consistent, but without full assessment), or had death by circulatory criteria (DCC) within 2 hours of withdrawal of life-sustaining measures (WLSMs). Missed donation opportunities were defined as occurring when there was no evidence in the medical record that the family of an eligible potential donor was approached regarding donation. Multivariable logistic regression was performed to identify predictors of missed opportunities. There were 3481 patients and 1072 eligible potential organ donors, including 481 with confirmed DNC, 154 with probable DNC, and 437 with DCC within 2 hours of WLSM. There were 172 (16%) missed organ donation opportunities. In multivariable analysis, risk factors included older age (odds ratio [OR] per decade, 1.1 [1.0-1.3]), death in an ED rather than ICU (OR, 5.4 [3.0-10.0]), death in a regional rather than urban hospital (OR, 2.8 [1.7-4.6]), and DCC rather than DNC (6.7 [4.4-10.1]). Missed opportunities were less common when the most responsible physician was a donation specialist (OR, 0.3 [0.2-0.5]). Missed cases categorized as probable DNC were proportionally more common in EDs (45%) than in ICUs (21%; p = 0.0005).

CONCLUSIONS: Missed organ donation opportunities occur with regularity, especially in EDs and regional hospitals, and among older patients and potential DCC donors. Donation physicians are likely to have a positive impact in reducing missed opportunities.

**中文摘要译文：**
目的：确定错失器官捐献机会的发生率和预测因素。

设计：基于人群的前瞻性队列研究。

地点：加拿大一个拥有500万人口省份的所有成人ICU和PICU（内科、外科、神经科和心血管科）以及急诊科（ED）。

患者：连续纳入的因各种病因导致毁灭性脑损伤而死亡的患者，他们在生命的最后12小时内接受了机械通气，研究周期为42个月。

干预措施：无。

测量与主要结果：如果患者被诊断为神经学标准死亡（DNC）、疑似DNC（神经系统检查结果一致，但未进行全面评估），或在撤除生命维持措施（WLSMs）后2小时内符合循环标准死亡（DCC），则被定义为符合条件的潜在捐献者。当医疗记录中没有证据表明曾就捐献事宜与符合条件的潜在捐献者家属进行过沟通时，即定义为发生了错失的捐献机会。采用多变量逻辑回归分析来识别错失机会的预测因素。研究共纳入3481名患者和1072名符合条件的潜在器官捐献者，其中包括481名确诊DNC者，154名疑似DNC者，以及437名在撤除生命维持措施后2小时内符合DCC标准者。共发生了172例（16%）错失的器官捐献机会。在多变量分析中，风险因素包括年龄较大（每十年OR值为1.1 [1.0-1.3]）、在急诊科而非ICU死亡（OR, 5.4 [3.0-10.0]）、在地区医院而非城市医院死亡（OR, 2.8 [1.7-4.6]），以及符合DCC标准而非DNC标准（6.7 [4.4-10.1]）。当主要负责医生是捐献专家时，错失机会的情况较少（OR, 0.3 [0.2-0.5]）。归类为疑似DNC的错失案例在急诊科（45%）的比例显著高于ICU（21%；p = 0.0005）。

结论：错失器官捐献机会的情况时常发生，尤其是在急诊科和地区医院，以及年龄较大和潜在的DCC捐献者中。捐献专科医生可能对减少错失机会产生积极影响。

### 第二部分 AI 大师评价

该研究通过一项大规模、基于人群的前瞻性队列研究，系统地探究了毁灭性脑损伤患者中器官捐献机会错失的发生率及其关键预测因素。其核心发现揭示了高达16%的机会被错失，并精准定位了高风险场景（如急诊科、地区医院）与高风险人群（如高龄、循环标准死亡者）。这项研究的价值在于其提供了强有力的省级数据证据，为优化器官捐献流程提供了明确的干预靶点，特别是强调了捐献专科医生在识别并转化潜在捐献者中的关键作用，对提升器官获取率具有重要的临床指导意义和公共卫生价值。

---

## 9. 影响中低收入国家脓毒症结局的因素：抗菌药物使用时机、是否存在休克还是支持治疗？

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41269052](https://pubmed.ncbi.nlm.nih.gov/41269052)
**期刊：** Critical care medicine
**PMID：** 41269052
**DOI：** 10.1097/CCM.0000000000006973

### 第一部分 原文与翻译

**英文原标题：** What Impacts Sepsis Outcomes in Low- and Middle-Income Countries: Antibiotic Timing, Presence of Shock, or Supportive Care?

**英文摘要原文：**
No abstract available.

**中文摘要译文：**
暂无摘要。

### 第二部分 AI 大师评价

本研究旨在探讨在中低收入国家（LMICs）中影响脓毒症患者预后的关键因素，重点比较了抗菌药物使用时机、是否存在休克以及支持治疗这三者的相对重要性。从标题推断，该研究可能通过临床数据分析，试图为资源受限环境下的脓毒症管理提供循证依据，以优化治疗策略。其临床价值在于帮助医生在复杂的临床情境中识别并优先处理最关键的治疗环节，从而改善患者结局。由于暂无摘要，无法获知其具体研究方法和核心发现，但该研究提出的问题对于全球脓毒症防治具有重要的现实意义。

---

速递结束，祝您工作愉快！